New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 6, 2018 - ITF Pharma announced the FDA approval of Tiglutik (riluzole), for the treatment of amyotrophic lateral sclerosis (ALS).
Download PDF
Return to publications
